These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? Newman DJ J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402 [No Abstract] [Full Text] [Related]
43. March of the synthesis machines. Sanderson K Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572 [No Abstract] [Full Text] [Related]
44. Identification of the cellular targets of bioactive small organic molecules using affinity reagents. Leslie BJ; Hergenrother PJ Chem Soc Rev; 2008 Jul; 37(7):1347-60. PubMed ID: 18568161 [TBL] [Abstract][Full Text] [Related]
45. Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists. Raveglia LF; Giardina GA Future Med Chem; 2009 Sep; 1(6):1019-23. PubMed ID: 21425990 [No Abstract] [Full Text] [Related]
46. Organic synthesis in flow for medicinal chemistry. Wirth T Bioorg Med Chem; 2017 Dec; 25(23):6179. PubMed ID: 29153554 [No Abstract] [Full Text] [Related]
47. Enterprising drug company offers cash for chemicals. Adam D Nature; 2001 Aug; 412(6847):575. PubMed ID: 11493887 [No Abstract] [Full Text] [Related]
48. The role of cocrystals in pharmaceutical science. Shan N; Zaworotko MJ Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562 [TBL] [Abstract][Full Text] [Related]
49. Greener pharmaceuticals. Clark JH; Breeden SW; Summerton L Future Med Chem; 2009 Jun; 1(3):409-13. PubMed ID: 21426120 [No Abstract] [Full Text] [Related]
50. Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review. Gendrin C; Roggo Y; Collet C J Pharm Biomed Anal; 2008 Nov; 48(3):533-53. PubMed ID: 18819769 [TBL] [Abstract][Full Text] [Related]
51. The importance of chemistry for the future of the pharma industry. Wild H; Heimbach D; Huwe C Angew Chem Int Ed Engl; 2011 Aug; 50(33):7452-3. PubMed ID: 21818828 [No Abstract] [Full Text] [Related]
53. Ozonolysis applications in drug synthesis. Van Ornum SG; Champeau RM; Pariza R Chem Rev; 2006 Jul; 106(7):2990-3001. PubMed ID: 16836306 [No Abstract] [Full Text] [Related]
54. Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route. Butters M; Catterick D; Craig A; Curzons A; Dale D; Gillmore A; Green SP; Marziano I; Sherlock JP; White W Chem Rev; 2006 Jul; 106(7):3002-27. PubMed ID: 16836307 [No Abstract] [Full Text] [Related]
55. Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation. Moribe K; Tozuka Y; Yamamoto K Adv Drug Deliv Rev; 2008 Feb; 60(3):328-38. PubMed ID: 18006109 [TBL] [Abstract][Full Text] [Related]
56. In search of sustainability: process R&D in light of current pharmaceutical industry challenges. Federsel HJ Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405 [TBL] [Abstract][Full Text] [Related]
57. [Significance of new effective-substances for basic research]. Kobinger W Subsid Med; 1975; 1-2():13-5. PubMed ID: 1114844 [No Abstract] [Full Text] [Related]
58. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis. Carrier D; Eckers C; Arnoult T; Thurston T; Major H Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854 [No Abstract] [Full Text] [Related]